Cindy Bayley
Affiliate @ ARCH Venture Partners
Cindy Bayley is a startup investor at ARCH Venture Partners. Dr Bayley is an affiliate of ARCH who focuses on life-science businesses and is co-founder of several ARCH portfolio companies, including deCODE genetics, an Icelandic diagnostics company, Adolor, a pharmaceutical firm developing novel analgesics, and Elixir Pharmaceuticals, an anti-aging and metabolic disease company, and has been instrumental insourcing companies such as Alnylam Pharmaceuticals and Agios Pharmaceuticals. Early in her career, she was a field engineer with Schlumberger Offshore Services. Dr. Bayley holds a B.S. in Physics from the University of Rochester, and a Ph.D. in Virology and an M.B.A. from the University of Chicago.
Last updated:
For AI agents: llms.txt
About ARCH Venture Partners
ARCH invests primarily in companies co-founded by scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories.ARCH has raised ten venture fundstotaling over $3 billion and has invested in the venture capital rounds for more than 150 companies. ARCH investors include corporations, pension funds, endowment funds, financial institutions, and private investors.
ARCH Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Cindy Bayley
Affiliate
|
|||
Clinton Bybee
Co-Founder and Managing Director
|
|||
Hong Hou
Venture Partner
|
|||
Keith Crandell
Co-founder & Managing Director
|
|||
Kristina Burow
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
